Mineral transport across the placenta S M Husain, M Z Mughal
We here review the transport of three minerals which have in common their role in bone mineralisation, their active transport across the placenta, and the rise in their placental transport rate in late gestation. The growing and differentiating human fetus is entirely dependent on its mother for the supply of nutrients and oxygen and removal of waste products. In mammals, through most of gestation this exchange process takes place across the placenta, a highly complex organ which also has other functions. Despite much research, the physiology of placental exchange and especially its control remains a poorly understood subject.
To follow the literature, it is important to have a basic understanding of the concepts and terminology involved, which in the case of calcium are shown schematically in fig 1.
By the end of normal human pregnancy the fetus acquires approximately 28 g calcium, 16 g phosphorous and 0-7 g magnesium, mostly during the third trimester (fig 2) . Calcium, which is not only required for skele-', U) 0. Gestational age (weeks) Figure 2 (1) Influx of calcium ions from maternal plasma across the microvillous (maternal facing) trophoblastic membrane into the trophoblastic cytosol; (2) Movement of calcium through the cytosol without causing large fluctuations in the cytosolic ionised calcium concentration; (3) Efflux of calcium ions from cytosol across the basolateral (fetal facing) trophoblastic membrane and hence across the fetal capillary and endothelium into fetal plasma. In other transporting epithelia the intracellular ionised calcium concentration is maintained at a low resting value of 10-7M in comparison to the extracellular concentration of 10-3M. 9 Recently it has been shown that trophoblast cytosolic ionised calcium concentration is 4 2x10-8 M.10 It is thought that calcium enters the trophoblast as a charged ion'1 using a specific carrier in the microvillous membrane,12 13 probably under the influence of the combined electrical and chemical ionised calcium concentration gradient across the microvillous membrane.
An efficient mechanism for cytosolic compartmentalisation and/or buffering of calcium ions in transit is likely to exist in all calcium transporting epithelia if cell viability is to be preserved. Likely candidates for this process are cytosolic organelles such as mitochondria, Golgi and endoplasmic reticulum,"I 14 15 and calcium binding proteins (CaBP). The latter have been identified in animal'6 17 and human'8 placentas. In the rat, the rapid increase in placental concentration of CaBP and its mRNA during the period of increased rate of fetal growth and calcium accumulation in late gestation suggests that this protein may be involved in placental calcium transport. '6 19 CaBP may enhance the diffusion of calcium through an aqueous compartment, 20 Factors which might effect the net maternofetal transfer of calcium include maternal and fetal placental blood flows, maternal and fetal calcium concentrations, together with the activity of placental transport mechanisms and factors which regulate them. As already mentioned, fetal accumulation of calcium occurs mainly in the last third of pregnancy and, in keeping with this, maternofetal transport of calcium in the rat increases some 70-fold over the last six days of gestation.27 This is more than can be accounted for by an increase in functioning placental surface area or in blood flow. To account for the total fetal content of calcium in a normal full term infant, it has been calculated that 170 litres of maternal plasma would have to be cleared of its plasma calcium content.28 With an estimated uterine blood flow of 500 mi/min at term,29 the rate of calcium delivery to the placenta by the blood stream is unlikely to be directly rate-limiting in its maternofetal transfer. However, we have found that chronic reduction of uterine blood flow in the rat does result in decreased maternofetal transfer of calcium,30 perhaps through an indirect link such as placental ischaemia resulting in a depletion of the energy supply necessary for active placental calcium transport.
Indirect evidence suggests that the maternal plasma calcium concentration may also influence placental calcium transport. Maternal dietary deficiency leading to a maternal calcium concentration as low as 1-0 mmoll resulted in the birth of infants with rickets whose plasma calcium concentrations were around 1 -6 mmol/l.31 Poorly treated maternal hypoparathyroidism resulting in maternal hypocalcaemia can lead to transient congenital hyperparathyroidism32: it is postulated that under these conditions decreased net placental calcium transfer leads to fetal hypocalcaemia and it is this which in turn leads to fetal hyperparathyroidism. Conversely, transient neonatal hypoparathyroidism has been reported in infants born to hypercalcaemic mothers due to untreated hyperparathyroidism. 33 Thus, in humans, placental calcium transport may be dependent on maternal plasma calcium concentration. In animal studies divergent results have been obtained, suggesting marked species variation. For example, in the rat, chronic matemal hypocalcaemia induced by matemal vitamin D deficiency and thyroparathyroidectomy did not alter the matemofetal calcium flux compared with sham operated animals. 34 The placenta has no nerve supply and therefore the changing transport rate during gestation must be either an inbuilt effect of placental growth and differentiation or must result from changes in hormones (or other controlling factors) produced by the mother, fetus, or placenta itself. Calcium regulatory hormones include 1, 25- By contrast, in rats, matemal vitamin D deficiency did not affect total fetal calcium content,43 and there was no effect on the matemofetal calcium gradient after fetal nephrectomy.44 However, on the fetal side of the placenta, 1,25(OH)2D3 (whether injected subcutaneously into the fetus or perfused into the fetal side of the placental circulation) also had an effect in this species in that it stimulated matemofetal calcium flux across placentas of rat fetuses which had been previously parathyroidectomised by decapitation but not across placentas of intact fetuses.45 Because PTH is an important trophic stimulator of 1,25(OH)2D3 synthesis, it is likely that the parathyroidectomised fetuses had a lower plasma 1,25(OH)2D3 concentration compared with intact fetuses. This suggests that this hormone only stimulates placental calcium transfer when its plasma concentration is low to start with.45As might be expected from the above, PTH (when injected subcutaneously into the fetus but not when perfused on the fetal side of the placental circulation) stimulated placental calcium transfer across placentas of parathyroidectomised fetuses but not across placentas of intact fetuses. 45 In 1985 it was reported that the concentration of PTH bioactivity was higher in fetal than maternal plasma whereas the converse was true of the immunoreactivity of PTH.46 This led to the suggestion that the fetal parathyroids may secrete a second peptide which acts functionally, but not chemically, like PTH. It was later reported that addition of fetal parathyroid gland extract to autologous fetal blood used to perfuse placentas of thyroparathyroidectomised sheep fetuses in situ led to an increase in the rate of calcium accumulation in the fetal blood reservoir.47 Using a similar experimental model it has been shown that addition of PTHrP (isolated from a human cancer cell line) but not bovine PTH (1-84) or rat PTH (1-34) resulted in an increase in the rate of calcium accumulation in the fetal blood reservoir. 48 
Magnesium
The fetal plasma concentration of total and ultrafilterable magnesium again exceeds that of maternal plasma57 (table) , and a magnesium pump must therefore be postulated. In support of this, in the rat unidirectional maternofetal transfer of magnesium is considerably higher than that of a passive diffusional marker, is reduced by the addition of cyanide, is temperature dependent,58 and depends on the activity of a sodium/magnesium ion exchanger.59 Interestingly, amiloride, an inhibitor of other sodium exchangers, has been demonstrated to reduce fetal accumulation of magnesium when injected into pregnant rats.60
There is no direct information on the regulation of placental magnesium transport, but an insight can be gained by observing the effects of therapeutic and experimental manipulations of maternal magnesium concentration on fetal magnesium concentration and content. In humans, treatment of preeclampsia with intravenous magnesium sulphate led to maternal and fetal hypermagnesaemia,61 suggesting that either the 'magnesium pump' is not normally saturated and/or increased diffusion across the placenta. Again, there are differences between species: acute maternal hypermagnesaemia in the rat led to only a slight increase in fetal plasma magnesium concentration.62 Chronic magnesium deficiency in the rat, however, resulted in decreased fetal plasma magnesium concentration and in total fetal magnesium content. 5 
Conclusion
Placental transport of minerals and its regulation is a highly complex and largely ill understood phenomenon. Much of our knowledge remains fragmentary and there is a great deal that cannot be explained. For example, in relation to the three minerals discussed here, what are the precise placental mechanisms of transfer and are they controlled by maternal, fetal, or intrinsic placental factors or a combination of all three?; how do these factors interact with respect to maternal supply and fetal need?; and what 'switches on' the increased rate of transfer of these minerals in late gestation? These are just a few of the questions which need to be addressed before we achieve a fuller understanding of mineral transport across the placenta.
